Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 12 February 2009, Vol. 113, No. 7, pp. 1432-1443.
Prepublished online as a Blood First Edition Paper on October 14, 2008; DOI 10.1182/blood-2008-06-162263.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Methods, Table, and Figures
Right arrow All Versions of this Article:
blood-2008-06-162263v1
113/7/1432    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heuser, M.
Right arrow Articles by Aparicio, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heuser, M.
Right arrow Articles by Aparicio, S. A.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted June 10, 2008
Accepted September 18, 2008

Loss of MLL5 results in pleiotropic hematopoietic defects, reduced neutrophil immune function and extreme sensitivity to DNA demethylation

Michael Heuser, Damian B. Yap, Malina Leung, Teresa Ruiz de Algara, Alaeddin Tafech, Steven McKinney, John Dixon, Rosemary Thresher, Bill Colledge, Mark Carlton, R. Keith Humphries, and Samuel A. Aparicio*

Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada
Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, BC, Canada
Takeda Pharmaceuticals Cambridge Ltd., Cambridge, United Kingdom
Physiological Laboratory, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom
Department of Medicine, University of British Columbia, Vancouver, BC, Canada
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada

* Corresponding author; email: saparicio{at}bccrc.ca.

MLL5 is a divergent member of the Drosophila Trithorax-related SET and PHD domain-containing chromatin regulators that are involved in the regulation of transcriptional "memory" during differentiation. Human MLL5 is located on chromosome 7q22, that is frequently deleted in myeloid leukemias, suggesting a possible role in hemopoiesis. To address this question, we generated a loss of function allele (Mll5tm1Apa) in the murine Mll5 locus. Unlike other Mll genes, Mll5tm1Apa homozygous mice are viable but display defects in immunity and hematopoiesis. First, Mll5tm1Apa homozygous mice show increased susceptibility to spontaneous eye infections, associated with a cell-autonomous impairment of neutrophil function. Second, Mll5tm1Apa/tm1Apa mice exhibit a mild impairment of erythropoiesis. Third, Mll5tm1Apa/tm1Apa hematopoietic stem cells (HSCs) have impaired competitive repopulating capacity both under normal conditions and when subjected to self-renewal stimulation by NUP98-HOXA10. Fourth, Mll5tm1Apa homozygous HSCs show a dramatic sensitivity to DNA demethylation-induced differentiation (5-Azadeoxycytidine). Taken together our data show that MLL5 is involved in terminal myeloid differentiation and the regulation of HSC self-renewal by a mechanism that involves DNA methylation. These data warrant investigation of MLL5 expression levels as predictive marker of demethylating-agent response in patients with myelodysplastic syndromes and leukemias and identify MLL5 as a key regulator of normal hematopoiesis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

MLL5 governs hematopoiesis: a step closer
Han Liu, Todd D. Westergard, and James J.-D. Hsieh
Blood 2009 113: 1395-1396. [Full Text] [PDF]



This article has been cited by other articles:


Home page
BloodHome page
M. I. Mascarenhas, A. Parker, E. Dzierzak, and K. Ottersbach
Identification of novel regulators of hematopoietic stem cell development through refinement of stem cell localization and expression profiling
Blood, November 19, 2009; 114(21): 4645 - 4653.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Heuser, L. M. Sly, B. Argiropoulos, F. Kuchenbauer, C. Lai, A. Weng, M. Leung, G. Lin, C. Brookes, S. Fung, et al.
Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal
Blood, November 5, 2009; 114(19): 3983 - 3993.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Sebastian, P. Sreenivas, R. Sambasivan, S. Cheedipudi, P. Kandalla, G. K. Pavlath, and J. Dhawan
MLL5, a trithorax homolog, indirectly regulates H3K4 methylation, represses cyclin A2 expression, and promotes myogenic differentiation
PNAS, March 24, 2009; 106(12): 4719 - 4724.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Liu, T. D. Westergard, and J. J.-D. Hsieh
MLL5 governs hematopoiesis: a step closer
Blood, February 12, 2009; 113(7): 1395 - 1396.
[Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020